Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 49 studies | 56% ± 23% | |
endothelial cell of lymphatic vessel | 27 studies | 74% ± 20% | |
capillary endothelial cell | 18 studies | 63% ± 24% | |
endothelial cell of artery | 16 studies | 68% ± 25% | |
vein endothelial cell | 15 studies | 60% ± 24% | |
endothelial cell of vascular tree | 14 studies | 55% ± 17% | |
platelet | 9 studies | 28% ± 10% | |
pericyte | 6 studies | 39% ± 17% | |
glomerular endothelial cell | 4 studies | 40% ± 8% | |
podocyte | 3 studies | 64% ± 9% | |
endothelial cell of sinusoid | 3 studies | 52% ± 22% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 23% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 95% | 5878.72 | 2501 / 2642 | 100% | 92.63 | 705 / 705 |
thymus | 98% | 7999.90 | 641 / 653 | 95% | 24.11 | 573 / 605 |
lung | 100% | 24840.82 | 578 / 578 | 85% | 19.00 | 977 / 1155 |
prostate | 74% | 2896.93 | 181 / 245 | 89% | 15.59 | 446 / 502 |
bladder | 95% | 6009.76 | 20 / 21 | 63% | 10.53 | 315 / 504 |
breast | 100% | 25889.23 | 458 / 459 | 58% | 9.96 | 644 / 1118 |
esophagus | 82% | 4214.03 | 1183 / 1445 | 69% | 12.23 | 126 / 183 |
uterus | 97% | 6577.48 | 165 / 170 | 53% | 10.87 | 242 / 459 |
intestine | 87% | 4179.44 | 841 / 966 | 58% | 8.06 | 306 / 527 |
kidney | 63% | 1837.62 | 56 / 89 | 78% | 19.61 | 706 / 901 |
stomach | 48% | 1619.94 | 174 / 359 | 64% | 10.55 | 183 / 286 |
skin | 65% | 3736.93 | 1175 / 1809 | 38% | 5.02 | 177 / 472 |
pancreas | 9% | 287.45 | 29 / 328 | 93% | 24.38 | 165 / 178 |
adipose | 100% | 22999.21 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.10 | 1 / 1 |
adrenal gland | 12% | 305.71 | 30 / 258 | 87% | 20.09 | 200 / 230 |
lymph node | 0% | 0 | 0 / 0 | 90% | 20.68 | 26 / 29 |
ovary | 47% | 1743.63 | 84 / 180 | 43% | 5.05 | 183 / 430 |
liver | 4% | 123.14 | 8 / 226 | 82% | 17.60 | 332 / 406 |
muscle | 80% | 3342.83 | 640 / 803 | 0% | 0 | 0 / 0 |
spleen | 76% | 2508.64 | 182 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 71% | 7.54 | 32 / 45 |
eye | 0% | 0 | 0 / 0 | 55% | 5.02 | 44 / 80 |
heart | 50% | 2196.21 | 432 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 48% | 2211.47 | 644 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 9.91 | 4 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007043 | Biological process | cell-cell junction assembly |
GO_0003151 | Biological process | outflow tract morphogenesis |
GO_1990963 | Biological process | establishment of blood-retinal barrier |
GO_0042552 | Biological process | myelination |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0007612 | Biological process | learning |
GO_1903142 | Biological process | positive regulation of establishment of endothelial barrier |
GO_0043116 | Biological process | negative regulation of vascular permeability |
GO_0032092 | Biological process | positive regulation of protein binding |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0007155 | Biological process | cell adhesion |
GO_1903348 | Biological process | positive regulation of bicellular tight junction assembly |
GO_0045471 | Biological process | response to ethanol |
GO_0016338 | Biological process | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules |
GO_0016525 | Biological process | negative regulation of angiogenesis |
GO_0060021 | Biological process | roof of mouth development |
GO_0070830 | Biological process | bicellular tight junction assembly |
GO_0035633 | Biological process | maintenance of blood-brain barrier |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0030336 | Biological process | negative regulation of cell migration |
GO_0060325 | Biological process | face morphogenesis |
GO_0007179 | Biological process | transforming growth factor beta receptor signaling pathway |
GO_0120192 | Biological process | tight junction assembly |
GO_0070160 | Cellular component | tight junction |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0030864 | Cellular component | cortical actin cytoskeleton |
GO_0005911 | Cellular component | cell-cell junction |
GO_0043220 | Cellular component | Schmidt-Lanterman incisure |
GO_0033270 | Cellular component | paranode region of axon |
GO_0016328 | Cellular component | lateral plasma membrane |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0030054 | Cellular component | cell junction |
GO_0016327 | Cellular component | apicolateral plasma membrane |
GO_0042802 | Molecular function | identical protein binding |
GO_0005198 | Molecular function | structural molecule activity |
GO_0005515 | Molecular function | protein binding |
Gene name | CLDN5 |
Protein name | Claudin 5 Claudin-5 (Transmembrane protein deleted in VCFS) (TMDVCF) |
Synonyms | AWAL TMVCF hCG_17893 |
Description | FUNCTION: Plays a major role in tight junction-specific obliteration of the intercellular space. . |
Accessions | ENST00000413119.2 ENST00000403084.1 D3DX19 ENST00000618236.2 O00501 ENST00000406028.1 |